非佐奈坦 Fezolinetant
【化学名】Fezolinetant
【原研】Euroscreen
【上市时间】2023年5月12日
【用途】用于治疗血管舒缩症和热潮红。
【剂型/规格】口服片剂，45 mg
非佐奈坦Fezolinetant
一、产品概述
Fezolinetant是由Euroscreen研发的一种小分子药物，是一种NK3R拮抗剂。于2023年05月12日获得美国食品药品管理局FDA批准，用于治疗血管舒缩症和热潮红。
二、主要产品
Description | Structural Formula | CAS No. | Category |
Fezolinetant |
| 1629229-37-3 | API |
(R)-4-(2,4-dimethoxybenzyl)-3-methylpiperazin-2-one |
| 1383146-20-0 | intermediates |
tert-butyl (R)-2-methyl-3-oxopiperazine-1-carboxylate |
| 1629229-82-8 | intermediates |
3-methyl-1,2,4-thiadiazole-5-carbohydrazide |
| 1375066-73-1 | intermediates |
4-fluorobenzoic acid |
| 456-22-4 | intermediates |
Note: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement and its liability is at buyer's risk.